92 related articles for article (PubMed ID: 370586)
1. Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.
Schneider JA; Schlesselman JJ; Mendoza SA; Orloff S; Thoene JG; Kroll WA; Godfrey AD; Schulman JD
N Engl J Med; 1979 Apr; 300(14):756-9. PubMed ID: 370586
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine therapy for children with nephropathic cystinosis.
Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid treatment in nephropathic cystinosis in identical twins.
Oberfield SE; Levine LS; Wellner D; Novogroder M; Laino P; New MI
Dev Pharmacol Ther; 1981; 2(2):80-90. PubMed ID: 7472109
[TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of cystinosis in children with twice-daily cysteamine.
Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
[TBL] [Abstract][Full Text] [Related]
6. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.
Thoene JG; Oshima RG; Crawhall JC; Olson DL; Schneider JA
J Clin Invest; 1976 Jul; 58(1):180-9. PubMed ID: 932205
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
[TBL] [Abstract][Full Text] [Related]
8. Improved renal function in children with cystinosis treated with cysteamine.
Markello TC; Bernardini IM; Gahl WA
N Engl J Med; 1993 Apr; 328(16):1157-62. PubMed ID: 8455682
[TBL] [Abstract][Full Text] [Related]
9. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
Creagan ET; Moertel CG; O'Fallon JR; Schutt AJ; O'Connell MJ; Rubin J; Frytak S
N Engl J Med; 1979 Sep; 301(13):687-90. PubMed ID: 384241
[TBL] [Abstract][Full Text] [Related]
10. Cystinosis and its therapy.
Segal S
N Engl J Med; 1979 Apr; 300(14):789-90. PubMed ID: 423913
[No Abstract] [Full Text] [Related]
11. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
[TBL] [Abstract][Full Text] [Related]
12. Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid.
Kroll WA; Schneider JA
Science; 1974 Dec; 186(4168):1040-2. PubMed ID: 4469696
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
15. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
[TBL] [Abstract][Full Text] [Related]
16. The in vivo use of dithiothreitol in cystinosis.
Depape-Brigger D; Goldman H; Scriver CR; Delvin E; Mamer O
Pediatr Res; 1977 Feb; 11(2):124-31. PubMed ID: 840501
[TBL] [Abstract][Full Text] [Related]
17. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
Lewis EJ; Hunsicker LG; Bain RP; Rohde RD
N Engl J Med; 1993 Nov; 329(20):1456-62. PubMed ID: 8413456
[TBL] [Abstract][Full Text] [Related]
18. Effects of cysteamine therapy in nephropathic cystinosis.
Yudkoff M; Foreman JW; Segal S
N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733
[TBL] [Abstract][Full Text] [Related]
19. Factors controlling the nonprotein cystine content of cystinotic fibroblasts.
Crawhall JC; Oshima RG; Schneider JA
Pediatr Res; 1977 Jan; 11(1 Pt 1):41-5. PubMed ID: 831218
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.
Lebel MH; Freij BJ; Syrogiannopoulos GA; Chrane DF; Hoyt MJ; Stewart SM; Kennard BD; Olsen KD; McCracken GH
N Engl J Med; 1988 Oct; 319(15):964-71. PubMed ID: 3047581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
